Guangdong Taienkang Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate
Guangdong Taienkang Pharmaceutical Co. Ltd cash flow reinvestment rate. Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Cash Flow Reinvestment Rate of 2.26x as of December 2024, reinvesting CN¥202.08 Million (capex CN¥68.55 Million plus investments CN¥133.53 Million) from operating cash flow of CN¥89.33 Million. See 301263 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2024)
Cash flow reinvestment rate of Guangdong Taienkang Pharmaceutical Co. Ltd from 2019 to 2024. Historical reinvestment intensity for Guangdong Taienkang Pharmaceutical Co. Ltd across 6 annual periods. Explore cash flow to debt ratio of Guangdong Taienkang Pharmaceutical Co. L to assess how comfortably operating cash covers total debt obligations.
Guangdong Taienkang Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate by Year (2019–2024)
Guangdong Taienkang Pharmaceutical Co. Ltd cash flow reinvestment rate by year from 2019 to 2024. Year-by-year capital reinvestment analysis for Guangdong Taienkang Pharmaceutical Co. Ltd. For the full cash flow conversion analysis, see 301263 cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.26x | CN¥202.08 Million | CN¥89.33 Million | CN¥68.55 Million | ▼ -64.2% |
| 2023 | 6.32x | CN¥590.93 Million | CN¥93.53 Million | CN¥200.01 Million | ▲ +112.3% |
| 2022 | 2.98x | CN¥442.89 Million | CN¥148.81 Million | CN¥89.88 Million | ▲ +301.6% |
| 2021 | 0.74x | CN¥88.93 Million | CN¥120.02 Million | CN¥44.65 Million | ▼ -49.9% |
| 2020 | 1.48x | CN¥185.71 Million | CN¥125.53 Million | CN¥93.12 Million | ▲ +531.7% |
| 2019 | 0.23x | CN¥17.67 Million | CN¥75.44 Million | CN¥8.83 Million | — |